Raymond James sees strong demand for APOL1-mediated FSGS therapies
Go back to Raymond James sees strong demand for APOL1-mediated FSGS therapies| (NASDAQ: MAZE) | Delayed: 26.38 +0.50 (1.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.88 | 52 Week High | $ | |||
| Open | $25.88 | 52 Week Low | $ | |||
| Day High | $26.77 | P/E | N/A | |||
| Day Low | $25.88 | EPS | $ | |||
| Volume | 162,423 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 506.90 +3.65 (0.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $503.25 | 52 Week High | $134.71 | |||
| Open | $502.11 | 52 Week Low | $73.31 | |||
| Day High | $514.90 | P/E | N/A | |||
| Day Low | $502.06 | EPS | $-1.98 | |||
| Volume | 324,496 | |||||



